Form 4: Marsh & McLennan CFO Mark McGivney Reports Stock Sales and Option Exercises
SEC Form 4
Mark McGivney, CFO of Marsh & McLennan Companies, reported the exercise of stock options and subsequent sale of common stock, according to a Form 4 filing with the SEC.
Summary
- Mark McGivney, the Chief Financial Officer of Marsh & McLennan Companies, Inc., filed a Form 4 with the SEC.
- The filing reports the exercise of stock options and the sale of common stock on August 2, 2024, and August 5, 2024.
- On August 2, 2024, McGivney exercised options to acquire 10,265 shares at a price of $118.865 per share and sold 10,265 shares at $118.865.
- Also on August 2, 2024, McGivney sold 3,791 shares at a weighted average price of $225.7664, 6,074 shares at a weighted average price of $226.7542, and 400 shares at a weighted average price of $227.3075.
- On August 5, 2024, McGivney exercised options to acquire 5,200 shares at a price of $118.865 per share and sold 5,200 shares at $118.865.
- Also on August 5, 2024, McGivney sold 5,200 shares at a price of $225.03.
- Following these transactions, McGivney directly owns 33,678 shares of common stock and 50,928 stock options.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions by an officer under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors monitor these filings to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-arranged trading plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 02/19/2020 | Options were granted |
| 02/19/2021 | First vesting date of options |
| 02/19/2022 | Second vesting date of options |
| 02/19/2023 | Third vesting date of options |
| 02/19/2024 | Fourth vesting date of options |
| 08/02/2024 | Date of stock option exercise and stock sales |
| 08/05/2024 | Date of stock option exercise and stock sales |
| 08/06/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.